National Advertising Review Board

NARB Panel Finds Meda Can Support ‘Faster’ Sleep Claims for MidNitePM, but Recommends Company Discontinue Pain-Relief Claims

A five-member panel of NARB has determined that that Meda Consumer Healthcare, Inc., maker of the dietary supplement “MidNite PM,” provided a reasonable basis in support of claims that the product promotes faster sleep and lets users wake without grogginess. The NARB panel recommended, however, that Meda discontinue claims that the product promotes “fast” sleep or can be used to manage pain.

Read More

NAD Finds L’Oreal Can Support Mascara Performance Claims, But Recommends Company Disclose Lash Inserts in Main Message of Ad or Discontinue Use of Enhancements; Company to Appeal to NARB

NAD has determined that L’Oreal U.S.A., Inc., can support certain performance claims for two mascara products. NAD has recommended, however, that the company discontinue the use of eyelash inserts in mascara advertisements that also make quantified performance claims or explicitly tell consumers – in the main message of the advertisement – that an image depicts the use of both mascara and lash inserts. L’Oreal has said it will appeal NAD’s decision to the National Advertising Review Board.

Read More

National Advertising Review Board Finds Matrixx Claims for Zicam Don’t Mislead Consumers

NARB has determined that certain claims made by Matrixx Initiatives for its Zicam Cold Remedy products would not reasonably be understood to mean that use of the products prevents colds.

Read More

NARB Recommends Healthy Directions Discontinue Certain Claims at Issue for ‘Joint Advantage Gold’ Supplement

NARB has recommended that Healthy Directions, LLC, discontinue certain advertising claims for the company’s Joint Advantage Gold dietary supplement, including claims that the product eases pain in seven days and is made with ingredients traditionally used by the Aboriginal people of Australia.

Read More

NARB Recommends Origins Discontinue Claims That Plantscription Anti-Aging Serum Rivals Anti-Wrinkle Prescriptions; Finds for Advertiser on All Additional Claims

A five-person panel of NARB has recommended that Origins Natural Resources, Inc., discontinue advertising claims that Plantscription Anti-aging serum rivals an anti-wrinkle prescription and provides 88 percent of the visible wrinkle-reducing power of a prescription.

Read More

NARB Finds Oracle Took Necessary Action in Discontinuing Comparative Performance Claims for Exadata

A five-member panel of the National Advertising Review Board has determined that Oracle Corporation acted properly in discontinuing comparative product-performance claims for the company’s Exadata database machines. The claims at issue were challenged byIBM.

Read More